Protein therapeutics: a summary and pharmacological classification
B Leader, QJ Baca, DE Golan - Nature reviews Drug discovery, 2008 - nature.com
Once a rarely used subset of medical treatments, protein therapeutics have increased
dramatically in number and frequency of use since the introduction of the first recombinant …
dramatically in number and frequency of use since the introduction of the first recombinant …
Acute coronary syndromes: diagnosis and management, part I
A Kumar, CP Cannon - Mayo Clinic Proceedings, 2009 - Elsevier
The term acute coronary syndrome (ACS) refers to any group of clinical symptoms
compatible with acute myocardial ischemia and includes unstable angina (UA), non—ST …
compatible with acute myocardial ischemia and includes unstable angina (UA), non—ST …
Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council …
HP Adams Jr, G Del Zoppo, MJ Alberts, DL Bhatt… - Stroke, 2007 - Am Heart Assoc
Purpose—Our goal is to provide an overview of the current evidence about components of
the evaluation and treatment of adults with acute ischemic stroke. The intended audience is …
the evaluation and treatment of adults with acute ischemic stroke. The intended audience is …
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation
Background A substantial proportion of patients receiving fibrinolytic therapy for myocardial
infarction with ST-segment elevation have inadequate reperfusion or reocclusion of the …
infarction with ST-segment elevation have inadequate reperfusion or reocclusion of the …
Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction
ContextRapid time to treatment with thrombolytic therapy is associated with lower mortality in
patients with acute myocardial infarction (MI). However, data on time to primary angioplasty …
patients with acute myocardial infarction (MI). However, data on time to primary angioplasty …
Management of acute myocardial infarction in patients presenting with ST-segment elevation
F Van de Werf, D Ardissino, A Betriu… - European heart …, 2003 - academic.oup.com
The management of acute myocardial infarction continues to undergo major changes. Good
practice should be based on sound evidence derived from well-conducted clinical trials …
practice should be based on sound evidence derived from well-conducted clinical trials …
Association of hemoglobin levels with clinical outcomes in acute coronary syndromes
MS Sabatine, DA Morrow, RP Giugliano, PBJ Burton… - Circulation, 2005 - Am Heart Assoc
Background—In the setting of an acute coronary syndrome (ACS), anemia has the potential
to worsen myocardial ischemia; however, data relating anemia to clinical outcomes in ACS …
to worsen myocardial ischemia; however, data relating anemia to clinical outcomes in ACS …
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force …
SC Smith Jr, TE Feldman, JW Hirshfeld Jr… - Journal of the American …, 2006 - Elsevier
The ACC/AHA Task Force on Practice Guidelines was formed to gather information and
make recommendations about appropriate use of technology for the diagnosis and …
make recommendations about appropriate use of technology for the diagnosis and …
Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy
CM Gibson, JA de Lemos, SA Murphy, SJ Marble… - Circulation, 2001 - Am Heart Assoc
Background—Use of abciximab in combination with administration of thrombolytics has
been shown to improve epicardial and microvascular coronary blood flow in acute …
been shown to improve epicardial and microvascular coronary blood flow in acute …
Facilitated PCI in patients with ST-elevation myocardial infarction
Background We hypothesized that percutaneous coronary intervention (PCI) preceded by
early treatment with abciximab plus half-dose reteplase (combination-facilitated PCI) or with …
early treatment with abciximab plus half-dose reteplase (combination-facilitated PCI) or with …